system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: BACKGROUND, RESULTS. Meshes: AMP-Activated Protein Kinases, Ataxia Telangiectasia Mutated Proteins, Autophagy, Cell Cycle Proteins, Cell Nucleus, Cell Survival, Cyclin-Dependent Kinase Inhibitor p21, DNA-Binding Proteins, Enzyme Activation, Fibroblasts, Glucose, Humans, Nuclear Proteins, Phosphoproteins, Phosphorylation, Protein-Serine-Threonine Kinases, RNA, Messenger, Signal Transduction, Transcriptional Activation, Tumor Suppressor Protein p53, Tumor Suppressor Proteins.
user
Does iFI16 induction by glucose restriction in human fibroblasts contribute to autophagy through activation of the ATM/AMPK/p53 pathway? Context: Glucose restriction in cells increases the AMP/ATP ratio (energetic stress), which activates the AMPK/p53 pathway. Depending upon the energetic stress levels, cells undergo either autophagy or cell death. Given that the activated p53 induces the expression of IFI16 protein, we investigated the potential role of the IFI16 protein in glucose restriction-induced responses. We found that glucose restriction or treatment of human diploid fibroblasts (HDFs) with the activators of the AMPK/p53 pathway induced the expression of IFI16 protein. The induced levels of IFI16 protein were associated with the induction of autophagy and reduced cell survival. Moreover, the increase in the IFI16 protein levels was dependent upon the expression of the functional ATM protein kinase. Importantly, the knockdown of the IFI16 expression in HDFs inhibited the activation of the ATM/AMPK/p53 pathway in response to glucose restriction and also increased the survival of HDFs.
assistant
Our observations demonstrate a role for the IFI16 protein in the energetic stress-induced regulation of autophagy and cell survival. Additionally, our findings also indicate that the loss of IFI16 expression, as found in certain cancers, may provide a survival advantage to cancer cells in microenvironments with low glucose levels. Final Decision: yes